The global epidemiology of vitiligo: A systematic review and meta‐analysis of the incidence and prevalence

Author:

Haulrig Morten Bahrt123ORCID,Al‐Sofi Rownaq13ORCID,Baskaran Subisan13ORCID,Bergmann Mie Siewertsen13ORCID,Løvendorf Marianne14ORCID,Dyring‐Andersen Beatrice145ORCID,Skov Lone123ORCID,Loft Nikolai13ORCID

Affiliation:

1. Department of Dermatology and Allergy Herlev and Gentofte Hospital Hellerup Denmark

2. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

3. Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital Hellerup Denmark

4. Leo Foundation Skin Immunology Research Center, Faculty of Health and Medical Sciences University of Copenhagen Kobenhavn Denmark

5. Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences University of Copenhagen Kobenhavn Denmark

Abstract

AbstractVitiligo is described with a prevalence of 0.5%−1%. Recent studies suggest an increasing prevalence, but there is a scarcity of studies that have systematically evaluated the global incidence and prevalence. We examined the incidence and the global, regional, and country‐specific prevalence of vitiligo in the general population (PROSPERO: CRD42021261643). We systematically searched PubMed, EMBASE, and Web of Science. Each study was categorised in subgroups. The overall analysis comprised all studies, except for studies only examining children and adolescents. Pooled proportions were calculated with the DerSimonian‐Laird method for random‐effects models with 95% confidence intervals (CI). Of the 7,838 identified studies, 171 were eligible for analysis (participants n = 572,334,973). The overall incidence was 1.59 per 10,000 person‐years (95% CI: 0.70−2.83). The overall prevalence was 0.40% (95% CI: 0.37−0.44); no difference was observed between females (0.50%, 95% CI: 0.36−0.66) and males (0.49%, 95% CI: 0.35−0.65). West Asia showed the highest prevalence (0.77%, 95% CI: 0.44−1.10) and East Asia the lowest (0.12%, 95% CI: 0.10−0.14). The highest country‐specific prevalence was reported in Jordan (1.34%, 95% CI: 0.12−3.87) and the lowest in Sweden (0.19%, 95% CI: 0.08−0.34). Children and adolescents showed a lower prevalence (0.27%, 95% CI: 0.24−0.31) compared to adults (0.70%, 95% CI: 0.59−0.81). Questionnaire‐based studies showed a higher prevalence (0.73%, 95% CI: 0.52−0.98) compared to examination‐based studies (0.59%, 95% CI: 0.46−0.73) and register‐based studies (0.13%, 95% CI: 0.10−0.17). The prevalence in examination‐based studies increased from 0.40% (95% CI: 0.17−0.73) between 1943 and 1979 to 0.89% (95% CI: 0.68−1.13) between 2020 and 2023. Questionnaire‐based studies also showed an increasing prevalence, while in register‐based studies, the prevalence was continuously low. This study shows the global impact of vitiligo and how subgroup analyses influence the prevalence. The overall prevalence of vitiligo is lower than previously assumed; females and males are equally affected, and vitiligo is more common in adults.

Funder

Novo Nordisk Fonden

Kongelig Hofbuntmager Aage Bangs Fond

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3